PedAM
Pediatric Disease Annotations & Medicines
| Disease | open-angle glaucoma |
| Phenotype | C0456909|blindness |
| Sentences | 8 |
| PubMedID- 23258653 | Risk factors for blindness in patients with open-angle glaucoma followed-up for at least 15 years. |
| PubMedID- 24647762 | Mutations in the human homolog of utp21, wdr36, have been associated with adult-onset primary open-angle glaucoma, a leading cause of blindness worldwide. |
| PubMedID- 24082707 | blindness due to primary open-angle glaucoma is more difficult to prevent and medication in open angle glaucoma could prevent the progression of the disease (grade a). |
| PubMedID- 23932216 | Purpose: to determine the lifetime risk and duration of blindness in patients with manifest open-angle glaucoma (oag). |
| PubMedID- 21051332 | Mutations in wd repeat domain 36 gene (wdr36) play a causative role in some forms of primary open-angle glaucoma, a leading cause of blindness worldwide. |
| PubMedID- 21887073 | Primary open-angle glaucoma was the cause of blindness in 25 (5%) subjects, most of whom were unemployed and had little education. |
| PubMedID- 26302445 | Prospective studies provided estimates for blindness due to primary open-angle glaucoma (poag) in at least one eye of 15–27%, and in both eyes of 6–12%, with incidence of about 1% per year (follow-up ranging from 15 to 34 years) [8–11], but other studies suggested that blindness incidence is declining due to the advent of modern treatments [12,13]. |
| PubMedID- 24823760 | Objective: to determine the longitudinal trends in the probability of blindness due to open-angle glaucoma (oag) in olmsted county, minnesota, from 1965 to 2009. |
Page: 1